Pfizer's ( PFE) second-quarter earnings topped the estimates of analysts on an adjusted basis as the results were impacted by foreign exchange and costs from the pending acquisition of Wyeth ( symbol).

Adjusted second-quarter earnings were $3.25 billion, or 48 cents a share, compared with $3.7 billion, or 55 cents a share a year earlier. Analysts surveyed by Thomson Reuters were expecting earnings of 47 cents a share.

Revenue in the quarter fell 9% to nearly $11 billion from $12.13 billion a year earlier. Pfizer said Wednesday that foreign exchange unfavorably impacted revenue by about $1.1 billion, or 9%. U.S. revenue in the period fell 5% to $4.5 billion, while international revenue declined by 12%.

Reported earnings in the quarter were $2.26 billion, or 34 cents a share, a decrease from $2.78 billion, or 41 cents a share, a year earlier.

The company raised its 2009 adjusted earnings guidance to $1.90 to $2 a share from a previous forecast of $1.85 to $1.95 a share. Analysts expect earnings of $1.96 a share.

If you liked this article you might like

Dow, S&P 500 Set New Records as Fed Moves to Unwind Balance Sheet

Stocks In Negative Territory as Chances for December Hike Surge

The Wait for 'Milestone' Fed Meeting Keeps Stocks in Flux

The 6 Medications Being Used to Tackle the Opioid Epidemic